DAM
AGN

Deltec Asset Management’s Allergan plc AGN Stock Holding History

Deltec Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-950
Closed -$200K – 193
2016
Q4 		$200K Sell
950
-12,500
-93% -$2.59M 0.05% 144
2016
Q3 		$3.1M Sell
13,450
-500
-4% -$122K 0.7% 46
2016
Q2 		$3.22M Buy
13,950
+13,000
+1,368% +$3M 0.81% 40
2016
Q1 		$255K Sell
950
-42,575
-98% -$12.2M 0.06% 119
2015
Q4 		$13.6M Sell
43,525
-2,800
-6% -$834K 3.46% 5
2015
Q3 		$12.6M Sell
46,325
-35,655
-43% -$11M 3.12% 5
2015
Q2 		$24.9M Buy
81,980
+4,750
+6% +$1.42M 5.47% 2
2015
Q1 		$23M Buy
77,230
+5,250
+7% +$1.5M 5.01% 4
2014
Q4 		$18.5M Sell
71,980
-5,030
-7% -$1.26M 4.06% 4
2014
Q3 		$18.6M Buy
77,010
+61,510
+397% +$13.8M 4.16% 4
2014
Q2 		$3.46M Buy
+15,500
New +$3.21M 0.73% 28

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deltec Asset Management's AGN Position: Q1 2017 in Review

Deltec Asset Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 950 shares — an estimated $200K sold.

Deltec Asset Management first reported a position in AGN in Q2 2014 and held it in 11 quarters. The position peaked at $24.9M in Q2 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Deltec Asset Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Deltec Asset Management sold 950 Allergan plc shares in Q1 2017, an estimated $200K.
  • Deltec Asset Management first reported a position in Allergan plc in Q2 2014 and held it in 11 quarters.
  • Deltec Asset Management's Allergan plc position peaked at $24.9M in Q2 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Deltec Asset Management's 13F filing for Q1 2017, filed 26 Apr 2017.